$18.65
0.39[2.14%]
At close: Apr 29
$18.65
0[0.00%]
After Hours: 6:38PM EDT
Privia Health Gr
(NASDAQ:PRVA)Privia Health Gr Stock (NASDAQ:PRVA), Analyst Ratings, Price Targets, Predictions
Privia Health Group Inc has a consensus price target of $33.67, established from looking at the 53 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, Canaccord Genuity, and JP Morgan on April 22, 2024, March 19, 2024, and March 6, 2024. With an average price target of $30.67 between Citigroup, Canaccord Genuity, and JP Morgan, there's an implied 64.43% upside for Privia Health Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Canaccord Genuity
JP Morgan
Barclays
UBS
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Privia Health Gr
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 34.05% | Citigroup | Daniel Grosslight | → $25 | Initiates | → Buy | Get Alert |
| 03/19/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 98.39% | Canaccord Genuity | Richard Close | $41 → $37 | Maintains | Buy | Get Alert |
| 03/06/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 60.86% | JP Morgan | Lisa Gill | $38 → $30 | Maintains | Overweight | Get Alert |
| 03/06/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 17.96% | Barclays | Andrew Mok | → $22 | Initiates | → Equal-Weight | Get Alert |
| 03/01/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 55.5% | UBS | Andrew Mok | $31 → $29 | Maintains | Buy | Get Alert |
| 03/01/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 39.41% | TD Cowen | Gary Taylor | $30 → $26 | Maintains | Outperform | Get Alert |
| 02/29/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 50.13% | Truist Securities | Jailendra Singh | $32 → $28 | Maintains | Buy | Get Alert |
| 02/28/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 34.05% | Evercore ISI Group | Elizabeth Anderson | $26 → $25 | Maintains | Outperform | Get Alert |
| 02/22/2024 | PRVA | Buy Now | Privia Health Gr | $18.65 | 12.6% | B of A Securities | Adam Ron | $27 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 44.77% | JMP Securities | Constantine Davides | → $27 | Initiates | → Market Outperform | Get Alert |
| 11/17/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 103.75% | JP Morgan | Lisa Gill | $43 → $38 | Maintains | Overweight | Get Alert |
| 08/18/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 71.58% | UBS | Andrew Mok | $35 → $32 | Maintains | Buy | Get Alert |
| 08/15/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 87.67% | TD Cowen | Gary Taylor | $44 → $35 | Maintains | Outperform | Get Alert |
| 06/22/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 119.84% | Credit Suisse | Jonathan Yon | → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 06/13/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 82.31% | Evercore ISI Group | Elizabeth Anderson | → $34 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 119.84% | Credit Suisse | Jonathan Yon | → $41 | Reiterates | → Outperform | Get Alert |
| 04/12/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 76.94% | Stephens & Co. | Jeff Garro | → $33 | Initiates | → Overweight | Get Alert |
| 03/10/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 93.03% | RBC Capital | Sean Dodge | → $36 | Initiates | → Outperform | Get Alert |
| 03/07/2023 | PRVA | Buy Now | Privia Health Gr | $18.65 | 119.84% | Credit Suisse | Jonathan Yong | → $41 | Reiterates | → Outperform | Get Alert |
FAQ
What is the target price for Privia Health Gr (PRVA)?
The latest price target for Privia Health Gr (NASDAQ: PRVA) was reported by Citigroup on April 22, 2024. The analyst firm set a price target for $25.00 expecting PRVA to rise to within 12 months (a possible 34.05% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Privia Health Gr (PRVA)?
The latest analyst rating for Privia Health Gr (NASDAQ: PRVA) was provided by Citigroup, and Privia Health Gr initiated their buy rating.
When was the last upgrade for Privia Health Gr (PRVA)?
The last upgrade for Privia Health Group Inc happened on February 22, 2022 when Cowen & Co. raised their price target to $35. Cowen & Co. previously had a market perform for Privia Health Group Inc.
When was the last downgrade for Privia Health Gr (PRVA)?
The last downgrade for Privia Health Group Inc happened on February 22, 2024 when B of A Securities changed their price target from $27 to $21 for Privia Health Group Inc.
When is the next analyst rating going to be posted or updated for Privia Health Gr (PRVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Privia Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Privia Health Gr was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Privia Health Gr (PRVA) correct?
While ratings are subjective and will change, the latest Privia Health Gr (PRVA) rating was a initiated with a price target of $0.00 to $25.00. The current price Privia Health Gr (PRVA) is trading at is $18.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.